Navigation Links
LSUHSC faculty shares inside knowledge in book to develop nation's research scientists
Date:11/19/2013

New Orleans, LA In his first book, Andrew D. Hollenbach, PhD, Associate Professor of Genetics at LSU Health Sciences Center New Orleans, shares his insider knowledge of how applications for one of the nation's most prestigious and sought-after series of training grants are reviewed, the biases that influence the process, and invaluable tips, insights and key suggestions. A Practical Guide to Writing a Ruth L. Kirschstein NRSA Grant by Andrew D. Hollenbach is published by Academic Press, an imprint of Elsevier.

The Kirschstein training grants, awarded on a competitive basis to students and postdoctoral researchers, play an important role in not only supporting career development, but also increasing the country's supply of scientists with both clinical knowledge as well as skills in basic, translational or clinical research. According to the National Institutes of Health, physicians/clinicians and trained scientists play a vital role in basic biomedical, translational, clinical, behavioral, epidemiologic, prevention, and services research. There is a critical need for physician and clinician-scientists to study human disease through rigorous research.

The application process for Ruth L. Kirschstein NRSA series F grants is very different from a typical research grant proposal. It is much more complex and much more involved. Evolving from advising students at LSU Health Sciences Center New Orleans one on one, to giving presentations, then seminars, a book was the next logical step. The book is Dr. Hollenbach's opportunity on a broader scale to pay forward the experience he's gained through his own professional development and serving as a reviewer on National Institutes of Health study section training review panels. The book, a resource that can be used by anyone anywhere, will not only benefit students and post-docs eligible for Kirschstein training grants, but their mentors and advisors as well.

"Many of these trainees and their mentors are nave of what is required to construct the best training grant they can possibly put together, as I was myself, and as such have grants returned to them, having not been discussed," says Dr. Hollenbach. "The more I saw this happening, the more I realized that I had a unique position from my repeat presence on study section to assist trainees and help them understand the extent of information needed for the application, the purpose of every component of the application, and provide insight into exactly what the reviewers are looking for and the biases and prejudices that exist in the reviewing process."

Dr. Hollenbach, who now holds three patents, continues to conduct basic research on biological mechanisms resulting in the development of cancer, particularly the childhood solid muscle tumor alveolar rhabdomyosarcoma (ARMS) and melanoma. He also continues to teach and mentor health professions students at LSU Health Sciences Center New Orleans and to serve as an ad hoc reviewer of national and international research journals.

A Practical Guide to Writing a Ruth L. Kirschstein NRSA Grant by Andrew D. Hollenbach is available at the Elsevier Store, Amazon.com, eBay, and a number of other booksellers.


'/>"/>

Contact: Leslie Capo
lcapo@lsuhsc.edu
594-568-4806
Louisiana State University Health Sciences Center
Source:Eurekalert

Related medicine news :

1. LSUHSCs Rodriguez receives cancer immunotherapy Presidential Award
2. Polish Academy Of Sciences awards LSUHSCs Bazan Medal
3. LSUHSC simulation or team training improves performance & patient safety
4. LSUHSC simulation or team training improves performance & patient safety
5. LSUHSC bird study finds key info about human speech-language development
6. LSUHSC study reports racial/ethnic differences in young people with cancer
7. LA Tumor Registry at LSUHSC receives $1.3 million from NCI
8. LSUHSC Dental School awarded $1.8 million for HIV care and education
9. LSUHSC research adds new info to improve pediatric dental sedation
10. LSUHSCs Hollier one of few ever awarded coveted national lectureship
11. LSUHSC paper judged best of the year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... , ... June 28, 2017 , ... ... is pleased to announce that a two year study conducted by the University ... Creek zeolite was successful in remediating potash brine-impacted groundwater. As a part of ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... ... protection assistance and financial consultations to communities in northern Virginia and DC, is ... to help provide for patients with Alzheimer’s and other disorders that lead to ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 percent of ... released today by the American Society for Dermatologic Surgery (ASDS). , ... of consumers considering a cosmetic medical procedure has doubled since 2013. , “Cosmetic ...
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, the ... the health care industry’s hospitals and provider groups, has announced that it will ... customers. Parasail Health is a San Francisco health-finance startup that has launched a ...
(Date:6/27/2017)... ... ... From June 20-22, EarQ and Widex held an exclusive training ... EarQ is headquartered. , Together, the organizations educate hearing care professionals on how ... the latest in hearing technology. At the event, EarQ members got an in-depth ...
Breaking Medicine News(10 mins):
(Date:6/5/2017)... , June 5, 2017 Kohll,s Pharmacy ... the United States . The Raizer is ... a fallen person up to an almost-standing position ... and operated by one assistant and does not ... is simple enough that a child can operate it, ...
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
(Date:5/30/2017)... May 30, 2017 Therapix Biosciences Ltd. (Nasdaq: ... in the development of cannabinoid-based drugs, today announced ... overview at three upcoming scientific and investor conferences ... Micro Invitational: ... Date:                     Wednesday, ...
Breaking Medicine Technology: